Business Daily Media

Business Marketing


NATA/RCPA accreditation pathology program

The National Association of Testing Authorities (NATA) together with the Royal College of Pathologists Australasia (RCPA) celebrate 40-years of accreditation in pathology.    

For anyone who has had a blood test or a COVID-19 Polymerase Chain Reaction (PCR) test, you have experienced first-hand the vital role that the NATA/RCPA pathology accreditation program plays in our daily lives.    

Reliable pathology results are critical to diagnosis, treatment and patient well-being. Accreditation provides confidence and assurance that pathology testing is being done competently to international standards using NATA’s world leading peer assessment model.   

Andrew Griffin, Sector Manager Legal and Clinical Services at NATA said: “The COVID pandemic has shone a very bright light on pathology and we congratulate the NATA/RCPA accredited laboratories on their rapid and successful response to the pandemic.    

“It is understood that there have been in excess of 35 million SARS-CoV-2 tests already processed and billed to Medicare. The public demands that the results of these laboratory tests can be relied on and accreditation provides that confidence.”     

“NATA has a long, strong and rich history in accreditation across many industries. For 75-years NATA has been a pioneering force and, as the world’s first accreditation body, has established accreditation programs across areas including construction mechanical testing, forensics and for the past 40 years pathology testing.       

“As more diseases and conditions emerge and re-emerge such as Monkeypox, Japanese encephalitis, Diphtheria and POLIO, accurate, reliable, high-quality testing will continue to play a vital role in keeping Australians safe.”    

Dr. Lawrie Bott, President of the RCPA, said: “The 40th anniversary of the NATA/RCPA accreditation program is an important milestone in this renowned accreditation program. One of the first accreditation programs of its type in the world, it has achieved the goals of its founders in both organisations, to raise laboratory standards for all laboratories, and to create patient safety.   

“Since its inception, referring doctors who received results from accredited laboratories had confidence in the quality of the results. Poorly performing laboratories that unfortunately did exist in earlier times, were forced to improve their quality or cease operations. The difference was almost instant, and the changes would have saved the lives of many Australians,” Bott noted.     

Australians will have felt the benefit of the NATA/RCPA accreditation program over the past four decades across elements including:    

·        1982: NATA/RCPA program introduced to standardise the testing process to ensure results being produced could be relied on.  

·        1986: Government enshrines the accreditation program’s importance with the Health Insurance Act, mandating that any laboratory wishing to claim MBS rebates has to be accredited.  

·        1991: Creation of the National Cervical Screening Program by Commonwealth Department of Health with NATA/RCPA accreditation supporting accurate and reliable testing. It’s led to Australia now being on track to be the first country globally to eliminate cervical cancer. 

·        2003: The International Standards Organisation published ISO 15189 for medical laboratories, introducing international standards for quality and competence that specifies the quality management system requirements particular to medical laboratories.  

·        2020: Western Diagnostic Pathology in Perth was granted the first accreditation for SARS-CoV-2 testing in Australia. There are now more than 230 NATA accredited sites across Australia. 

·        2022: In November a new version of the ISO 15189 Standard will be published with an increased focus on risk management and patient safety.    

The NATA/RCPA program accredits all pathology disciplines including:     

Anatomical Pathology (including tissues pathology, cytology and forensic pathology): Assisted reproductive technologies, Chemical Pathology, Genetic Pathology, Haematology and Immunohaematology, Immunopathology and Microbiology.    

To mark the NATA/RCPA 40-year anniversary, NATA has released its first publicly available pathology industry update. Some facts include:   

·        In 2021 NATA/RCPA had 745 accredited laboratories 

·        41% are public and 59% are private 

·        75% of assessments are completely closed out within four months of assessment date 

·        NATA has 829 volunteer pathology technical assessors.    

By recognising competent testing, measurement and inspection services that meet international standards of best practice, NATA’s accreditation services work in the national interest and make sure Australians can rely on the high standards of living we’ve come to enjoy. 


Candlefox continues its European growth

The education marketing company Candlefox is delighted to announce the forthcoming launch of the website - a digital comparison platform for those in the Republic of Ireland who are seeking both online and in-per...

Baraja surpasses 100 patent filings to advance IP portfolio globally

The key milestone demonstrates the company’s relentless commitment to innovation and solidifies its strong patents portfolio as an industry leader SYDNEY, Baraja, creator of breakthrough Spectrum-Scan™ LiDAR technology for auto...

Poor habits we picked up while working at home

For many of us, the disarray of working from home over the last couple of months while we juggle kids, home schooling and myriad distractions have likely resulted in the formation of some poor habits that negatively impact our p...